ArticleJournal of cardiology cases2025
Simultaneous coronary artery bypass grafting and transcarotid transcatheter aortic valve implantation using a cardiopulmonary bypass-assisted carotid perfusion.
Article in Journal of cardiology cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Managing severe aortic stenosis (AS) alongside complex coronary artery disease (CAD) in frail patients is challenging. A 79-year-old female with resting dyspnea was diagnosed with severe AS and CAD. While coronary artery bypass grafting (CABG) was the appropriate treatment for CAD, surgical aortic valve replacement was deferred due to a porcelain aorta and left ventricular dysfunction. The carotid approach was the only feasible option for transcatheter aortic valve implantation (TAVI), yet it posed an increased risk of ischemic stroke due to inadequate cerebral collateral circulation. She underwent simultaneous on-pump beating CABG and transcarotid TAVI using cardiopulmonary bypass with selective cerebral perfusion. A 20-mm Sapien 3 valve (Edwards Lifesciences, Irvine, CA, USA) was successfully implanted. Postoperatively, her condition improved without any signs of cerebral ischemia, and she was discharged in stable condition. This innovative approach ensured cerebral perfusion, minimized stroke risk, and effectively addressed severe CAD in a single procedure. Learning objective: To demonstrate the clinical applicability of combining coronary artery bypass grafting and transcatheter aortic valve implantation (TAVI) via carotid artery access in a small-statured, high-risk patient.To discuss the novel use of an extracorporeal cardiopulmonary bypass-assisted carotid perfusion or cerebral protection during TAVI in a patient with inadequate collateral cerebral circulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.